Effects of n-3 fatty acids during pregnancy and lactation

American Journal of Clinical Nutrition

Volumn 83, Issue 6, 2006, Pages

  Jensen, Craig L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Infant neurodevelopment; Infant visual function; Maternal depression; Maternal DHA supplementation; n 3 Fatty acids; Preeclampsia; Pregnancy

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

CONFERENCE PAPER; FAT INTAKE; HUMAN; ICOSANOID METABOLISM; LACTATION; LIPID STORAGE; NERVE CELL DIFFERENTIATION; NERVE MEMBRANE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RETINA; BRAIN; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; INFANT; MATERNAL NUTRITION; METABOLISM; NEWBORN; PREGNANCY COMPLICATION; PRENATAL DEVELOPMENT; PUERPERAL DEPRESSION; REVIEW;

BRAIN; DEPRESSION, POSTPARTUM; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MATERNAL NUTRITION PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL NUTRITION PHYSIOLOGY; RETINA;

EID: 33746788652     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.6.1452s     Document Type: Conference Paper

References (62)

1. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980;4:121-9.
2. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Extrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980;4:131-8.
3. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-38.
4. Holman RT, Johnson SB, Ogburn PL. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A 1991;88:4835-9.
5. Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr 1995;74:55-68.
6. Al MDM, van Houwelingen AC, Hornstra G. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 2000;71:285S-91S.
7. Makrides M, Gibson RA. Long-chain polyunsaturated fatty acid requirements during pregnancy and lactation. Am J Clin Nutr 2000;71:307S-11S.
8. de Groot RH, Hornstra G, van Houwelingen AC, Roumen F. Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am J Clin Nutr 2004;79:251-60.
9. Innis SM. Human milk and formula fatty acids. J Pediatr 1992;120:S56-61.
10. Koletzko B, Thiel I, Abiodun PO. The fatty acid composition of human milk in Europe and Africa. J Pediatr 1992;120:S62-70.
11. Jensen RG, Lammi-Keefe CJ, Henderson RA, Bush VJ, Ferris AM. Effect of dietary intake of n-6 and n-3 fatty acids on the fatty acid composition of human milk in North America. J Pediatr 1992;120:S87-92.
12. Gibson RA, Neumann MA, Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 1997;51:578-84.
13. Henderson RA, Jensen RG, Lammi-Keefe CJ, Ferris AM, Dardick KR. Effect of fish oil on the fatty acid composition of human milk and maternal and infant erythrocytes. Lipids 1992;27:863-9.
14. Jensen CL, Maude M, Anderson RE, Heird WC. Effect of docosahexaenoic acid supplementation of lactating women on the fatty acid composition of breast milk lipids and maternal and infant plasma phospholipids. Am J Clin Nutr 2000;71:292S-9S.
15. Francois CA, Connor SL, Bolewicz LC, Connor WE. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 2003;77:226-33.
16. Boris J, Jensen B, Salvig JD, Secher NJ, Olsen SF. A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n-3 fatty acid content in human breast milk. Lipids 2004;39:1191-6.
17. Olsen SF, Joensen HD. High liveborn birth weights in the Faroes: a comparison between birth weights in the Faroes and in Denmark. J Epidemiol Community Health 1985;39:27-32.
18. Olsen SF, Hansen HS, Sommer S, et al. Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: a study of women in the Faroe Islands and Denmark. Am J Obstet Gynecol 1991;164:1203-9.
19. Olsen SF, Secher NJ. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br J Nutr 1990;64:599-609.
20. Olsen SF, Hansen HS, Secher NJ, Jensen B, Sandstrom B. Gestation length and birth weight in relation to intake of marine n-3 fatty acids. Br J Nutr 1995;73:397-404.
21. Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001;73:807-14.
22. Grandjean P, Bjerve KS, Weihe P, Steuerwald U. Birthweight in a fishing community: significance of essential fatty acids and marine food contaminants. Int J Epidemiol 2001;30:1272-8.
23. Rump P, Mensink RP, Kester ADM, Hornstra G. Essential fatty acid composition of plasma phospholipids and birth weight: a study in term neonates. Am J Clin Nutr 2001;73:797-806.
24. Olsen SF, Sorensen JD, Secher NJ, et al. Randomized controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992;339:1003-7.
25. Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D. A randomized double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 1995;102:95-100.
26. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomized clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 2000;107:382-95.
27. Helland IB, Saugstad OD, Smith L, et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics [serial online] 2001;108:E82. Internet: http://pediatrics. aappublications.org/content/vol108/issue5/index.shtml (accessed 25 March 2006).
28. Olsen SF, Secher NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. BMJ 2002;324:447.
29. Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomized trial. Arch Dis Child Fetal Neonatal Ed 2003;88:F383-90.
30. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003;101:469-79.
31. Ogburn PL, Williams PP, Johnson SB, Holman RT. Serum arachidonic acid levels in normal and preeclamptic pregnancies. Am J Obstet Gynecol 1984;148:5-9.
32. Adair CD, Sanchez-Ramos L, Briones DL, Ogburn P. The effect of high dietary n-3 fatty acid supplementation on angiotensin II pressor response in human pregnancy. Am J Obstet Gynecol 1996;175:688-91.
33. Wang YP, Kay HH, Killam AP. Decreased levels of polyunsaturated fatty acids in preeclampsia. Am J Obstet Gynecol 1991;164:812-8.
34. D'Almeida A, Carter JP, Anatol A, Prost C. Effect of a combination of evening primrose oil (gamma-linolenic acid) and fish oil (eicosapentaenoic acid + docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992;19:117-31.
35. Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol 1993;168:915-22.
36. Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995;6:232-7.
37. Hibbeln JR, Nieminen LRG, Blasbalg TL, Riggs JA, Lands WEM. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006;83(suppl):1483S-93S.
38. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002;69:15-29.
39. Chiu CC, Huang SY, Shen WW, Su KP. Omega-3 fatty acids for depression in pregnancy. Am J Psychiatry 2003;160:385(letter).
40. De Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 2003;73:3181-7.
41. Otto SJ, de Groot RH, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 2003;69:237-43.
42. Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 2003;188:1348-53.
43. Marangell LB, Martinez JM, Zboyan HA, Chong H, Puryear LJ. Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depress Anxiety 2004;19:20-3.
44. Hibbeln JR, Davis JM, Heron J, Evans J, Wolke DFH, Golding J, ALSPAC Study Team. Low dietary omega-3s and increased depression risk in 14,541 pregnancies. American Psychiatric Association Annual Meeting, 2003, San Francisco, CA, New Research Abstracts [Abstract NR418]. Internet: http://www.psych.org/edu/other_res/lib_archives/archives/meetings/2003nra.htm (accessed 10 April 2006).
45. Freeman MP, Hibbeln JR, Wisner KL, Watchman M, Gelenberg AJ. An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatrica 2006;18:21-4.
46. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006;113:31-5.
47. de Groot RH, Adam J, Jolles J, Hornstra G. Alpha-linolenic acid supplementation during human pregnancy does not affect cognitive functioning. Prostaglandins Leukot Essent Fatty Acids 2004;70:41-7.
48. Rossi E, Costa M. Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies (APL): a pilot study. Lupus 1993;2:319-23.
49. Cheruku SR, Montgomery-Downs HE, Farkas SL, Thoman EB, Lammi-Keefe CJ. Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002;76:608-13.
50. Ghys A, Bakker E, Hornstra G, van den Hout M. Red blood cell and plasma phospholipids arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum Dev 2002;69:83-90.
51. Williams C, Birch EE, Emmett PM, Northstone K. Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC) Study Team. Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. Am J Clin Nutr 2001;73:316-22.
52. Innis SM, Gilley J, Werker J. Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants? J Pediatr 2001;139:532-8.
53. Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003;143(suppl):S1-8.
54. Malcolm CA, Hamilton R, McCulloch DL, Montgomery C, Weaver LT. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 2003;44:3685-91.
55. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics [serial online] 2003;111:e39. Internet: http://pediatrics.aappublications.org/content/vol111/ issue1/index.shtml (accessed 25 March 2006).
56. Colombo J, Kannass KN, Shaddy DJ, et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev 2004;75:1254-67.
57. Lauritzen L, Jorgensen MH, Mikkelsen TB, et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids 2004;39:195-206.
58. Jensen CL, Voigt RG, Prager TC, et al. Effects of docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 2005;82:125-32.
59. Simopoulos AP, Leaf A, Salem N. Conference report: workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 1999;18:487-9.
60. AOCS. Collected recommendations for long-chain polyunsaturated fatty acid intake. AOCS Inform 2003;14:762-3.
61. Benisek D, Shabert J, Skornik R. Dietary intake of polyunsaturated fatty acids by pregnant and lactating women in the United States. Obstet Gynecol 2000;95:S77-8.
62. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995;62:1-9.